Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Steven T. Rosen"'
Autor:
Swetha Kambhampati, Monica Saumoy, Yecheskel Schneider, Steve Serrao, Pejman Solaimani, Lihua Elizabeth Budde, Matthew G. Mei, Leslie L. Popplewell, Tanya Siddiqi, Jasmine Zain, Stephen J. Forman, Larry W. Kwak, Steven T. Rosen, Alexey V. Danilov, Alex F. Herrera, Nikhil R. Thiruvengadam
Publikováno v:
Blood. 140:2024-2036
The ZUMA-7 (Efficacy of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Subjects With Relapsed/Refractory Diffuse Large B Cell Lymphoma) study showed that axicabtagene ciloleucel (axi-cel) improved event-free survival (EFS) compared w
Autor:
Shuo Ma, Steven T. Rosen, Maria Winqvist, Olga Frankfurt, Jane N. Winter, Leo Gordon, Irene Helenowski, Hui Zhang, Jennifer Kreutzer, Sonja Sönnert-Husa, Anders Österborg, Jeanette Lundin
Publikováno v:
Leukemia research. 122
This phase 2 study describes long-term clinical and immunological effects of fixed-duration ofatumumab (anti-CD20) and alemtuzumab (anti-CD52) combination immunotherapy in 52 patients with previously untreated CLL. The median age was 65 years (range
Autor:
Steven M. Horwitz, Christian Gisselbrecht, Francine M. Foss, Massimo Federico, Andrei R. Shustov, Lisa A. Bellm, Barbara Pro, Lauren C. Pinter-Brown, Frederick Lansigan, Marc Schwartz, Eric D. Hsi, Kenneth R. Carson, Steven T. Rosen, Mark Acosta
Publikováno v:
Clin Lymphoma Myeloma Leuk
Introduction We examined patient characteristics, treatments and outcomes of transformed mycosis fungoides (tMF) patients from COMPLETE: a large, multicenter, prospective cohort study of peripheral T-cell lymphoma patients in the US. Methods Patients
Autor:
Lisa A. Bellm, Frederick Lansigan, John P. Greer, Massimo Federico, Anil Tulpule, Christian Gisselbrecht, Steven M. Horwitz, Marc Schwartz, Lauren C. Pinter-Brown, Steven T. Rosen, Neil Morganstein, Eric D. Hsi, Michael Craig, Francine M. Foss, Brad S. Kahl, Andrei R. Shustov, Barbara Pro, Mark Acosta, Tatyana Feldman, Ranjana H. Advani, Carla Casulo, Sonali M. Smith, Steven I. Park, Joseph W. Leach, Mary Jo Lechowicz
Background: Outcomes for patients with peripheral T-cell lymphoma (PTCL) who fail to achieve complete response (CR) or relapse after front-line therapy are poor with lack of prospective outcomes data. Objectives: COMPLETE is a prospective registry of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7034e2352d237626738b528489574d82
https://hdl.handle.net/11380/1201641
https://hdl.handle.net/11380/1201641
Autor:
Belén Rubio-González, Joan Guitart, Heather W. Wickless, Alba Posligua, Xiaolong Zhou, Kimberly A. Sable, Jaehyuk Choi, Maria Estela Martinez-Escala, Steven T. Rosen, Jason B. Kaplan, Audrey Rutherford, Christiane Querfeld, Barbara Pro
Publikováno v:
Journal of the American Academy of Dermatology. 78:1068-1076
Background Cutaneous lymphoma diagnosed after anti–tumor necrosis factor-α therapy (anti–TNF-α) has been reported in the literature, yet a clear link between both events remains elusive. Objective To review our experience with cutaneous lymphom
Autor:
Aliyah R. Sohani, Joycelynne Palmer, Alex F. Herrera, Yi-Bin Chen, Lihua E. Budde, Philippe Armand, Stephen J. Forman, Robert J. Soiffer, Christine Pak, Dennis D. Weisenburger, Amrita Krishnan, Jasmine Zain, Tanya Siddiqi, Wing C. Chan, Leslie Popplewell, Joseph H. Antin, Robert T. Chen, Liana Nikolaenko, John Koreth, Sarah Nikiforow, Dongyun Yang, Scott J. Rodig, German Pihan, Joyce Murata-Collins, Joo Y. Song, Matthew Mei, Larry W. Kwak, David M. Weinstock, Victoria Bedell, Corey Cutler, Auayporn Nademanee, Paola Dal Cin, Young L. Kim, Steven T. Rosen, Vincent T. Ho, Gabriel K. Griffin, Edwin P. Alyea, Raju Pillai
Publikováno v:
Biology of Blood and Marrow Transplantation. 24:514-520
Double-hit lymphomas (DHLs) and double-expressor lymphomas (DELs) are associated with resistance to frontline and salvage immunochemotherapy, as well as autologous stem cell transplantation (SCT). We hypothesized that allogeneic SCT (alloSCT) could o
Autor:
Aaron M. Gruver, Barbara Pro, Carla Casulo, Brad S. Kahl, Kenneth R. Carson, Samir K. Turakhia, Ranjana H. Advani, Steven M. Horwitz, Bartosz Grzywacz, Andrei R. Shustov, Steven I. Park, John P. Greer, Anil Tulpule, Angela M. B. Collie, Joseph W. Leach, Michael Craig, Christian Gisselbrecht, Mark Acosta, Marc Schwartz, Lauren Pinter-Brown, Massimo Federico, Lisa A. Bellm, Sonali M. Smith, Steven T. Rosen, Neil Morganstein, Tatyana Feldman, Francine M. Foss, Frederick Lansigan, Eric D. Hsi, Mary Jo Lechowicz
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 17:193-200
Background With increased understanding of the unique entities, subtype-specific approaches for peripheral T-cell lymphoma (PTCL) are emerging, and more precise diagnoses are becoming increasingly important. Patients and Methods We analyzed the appro
Autor:
Lawrence Low, Aliyah R. Sohani, Haesook T. Kim, Jennifer R. Brown, Victoria Bedell, Eric D. Jacobsen, Heather Sun, Steven T. Rosen, Scott J. Rodig, Joyce Murata-Collins, Stephen J. Forman, Jasmine Zain, Arnold S. Freedman, Alex F. Herrera, Gabriel K. Griffin, Robert T. Chen, Young Wan Kim, Ann S. LaCasce, Caron A. Jacobson, Christine Pak, Dennis D. Weisenburger, Tracey Stiller, Wing C. Chan, Joo Y. Song, Larry W. Kwak, Lihua E. Budde, Philippe Armand, Amrita Krishnan, Auayporn Nademanee, Matthew S. Davids, Tanya Siddiqi, Tanya Paris, Reid W. Merryman, German Pihan, Raju Pillai, Joycelynne Palmer, Matthew Mei, David C. Fisher, Leslie Popplewell, David M. Weinstock
Publikováno v:
Journal of Clinical Oncology. 35:24-31
Purpose Double-hit lymphomas (DHLs) and double-expressor lymphomas (DELs) are subtypes of diffuse large B-cell lymphoma (DLBCL) associated with poor outcomes after standard chemoimmunotherapy. Data are limited regarding outcomes of patients with rela
Autor:
Jessie Hou, Sandrine Puverel, Stephen J. Forman, Yuming Guo, Matthew Mei, Wing C. Chan, Xiwei Wu, Vu N. Ngo, Joo Y. Song, Shu Tao, Shuhua Yi, Timothy W. Synold, Larry W. Kwak, Lu Chen, Jun Wu, Alex F. Herrera, Leslie Popplewell, Edward M. Newman, Steven T. Rosen, Robert T. Chen
Publikováno v:
Clin Cancer Res
Purpose: In classical Hodgkin lymphoma, the malignant Reed–Sternberg cells express the cell surface marker CD30. Brentuximab vedotin is an antibody–drug conjugate (ADC) that selectively delivers a potent cytotoxic agent, monomethyl auristatin E (
Autor:
Lisa A. Bellm, Andrei R. Shustov, Steven I. Park, Barbara Pro, Massimo Federico, Joseph W. Leach, John P. Greer, Christian Gisselbrecht, Steven T. Rosen, Neil Morganstein, Steven M. Horwitz, Marc Schwartz, Anil Tulpule, Frederick Lansigan, Tatyana Feldman, Kenneth R. Carson, Eric D. Hsi, Ranjana H. Advani, Lauren C. Pinter-Brown, Michael Craig, Carla Casulo, Sonali M. Smith, Mark Acosta, Mary Jo Lechowicz, Francine M. Foss, Brad S. Kahl
Publikováno v:
Cancer
Background The role of autologous stem cell transplantation (ASCT) in the first complete remission (CR1) of peripheral T-cell lymphomas (PTCLs) is not well defined. This study analyzed the impact of ASCT on the clinical outcomes of patients with newl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7c551c73fd380c2664b15e97c60892e
https://hdl.handle.net/11380/1182200
https://hdl.handle.net/11380/1182200